Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 949-745-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15th of October 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- GLP compliant
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 438 (Isolated Chicken Eye Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- adopted 25 June 2018
- Deviations:
- yes
- Remarks:
- Deviation is considered as without impact on the results of the study.
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Certificate of Compliance with Good Laboratory Practices according to Directives 2004/9/CE and 2004/10/CE, Groupe Interministeriel des Produits Chimiques, Republique Francaise, Certificat n°: 2017/33, dated 27 April 2017
Test material
- Reference substance name:
- Esterification products of Guerbet alcohols, C24-26, branched and cyclic with benzene-1,2,4-tricarboxylic acid 1,2-anhydride (3:1)
- EC Number:
- 949-745-1
- Molecular formula:
- not applicable UVCB
- IUPAC Name:
- Esterification products of Guerbet alcohols, C24-26, branched and cyclic with benzene-1,2,4-tricarboxylic acid 1,2-anhydride (3:1)
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: supplied by the sponsor, Batch no.: 05347/MA
- Expiration date of the lot/batch: Retest date June 2022
- Purity test date: 31 August 2018
- Storage condition of test material: room temperature, darkness
Test animals / tissue source
- Species:
- other: isolated chicken eye
- Details on test animals or tissues and environmental conditions:
- SOURCE OF COLLECTED EYES
- Source: slaughterhouse Etablissement Brun, 33820 Etauliers, France, eyes collected from chicken killed for human consumption
- Number of animals: not mentioned
- Characteristics of donor animals: approx. 7 weeks old, 1.5 - 2.5 kg, sex not mentioned
- Storage, temperature and transport conditions of ocular tissue (e.g. transport time, transport media and temperature, and other conditions): Because eyes were dissected in the laboratory, the intact heads were transported from the slaughterhouse at ambient temperature in plastic boxes humidified with towels moistened with physiological saline. Eyes were enucleated at test laboratory and transferred to a chamber of the superfusion apparatus such that the entire cornea was supplied with the physiological saline drip in the range of 0.1 to 0.15 ml/min. at temperatures between 32.3 and 32.4 °C.
- Indication of any existing defects or lesions in ocular tissue samples: none
- Indication of any antibiotics used: not mentioned
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied: 30 µl
- Duration of treatment / exposure:
- 10 seconds, then rinsed from the eye with 20 ml of physiological saline at ambient temperature
- Duration of post- treatment incubation (in vitro):
- Treated corneas were evaluated at 30, 75, 120, 180, and 240 minutes after post-treatment rinse
- Number of animals or in vitro replicates:
- 3 replicates for the test item, 3 replicates for the positive control, 1 replicate for the negative control
- Details on study design:
- SELECTION AND PREPARATION OF ISOLATED EYES
The eyelids were carefully excised, taking care not to damage the cornea. Then, the eye was further dissected from the skull, taking care not to damage the cornea. The eyeball was pulled from the orbit by holding the nictitating membrane firmly with surgical forceps, and the eye muscles were cut with a bent, blunt-tipped scissor. When the eye was removed from the orbit, a visible portion of the optic nerve should be left attached. Once removed from the orbit, the eye was placed on an absorbent pad and the nictitating membrane and other connective tissue were cut away. The enucleated eye was mounted in a stainless steel clamp with the cornea positioned vertically. The clamp was then transferred to a chamber of the superfusion apparatus. The clamps were postioned in the superfusion apparatus such that the entire cornea was supplied with the physiological saline drip (in the range 0.1 to 0.15 mL/min). The chambers of the superfusion apparatus was temperature controlled between 32.3 and 32.4°C. After being placed in the superfusion apparatus, the eyes were examined with a slit-lamp microscope to ensure that they have not been damaged during the dissection procedur. Corneal thickness was also measured at this time at the corneal apex using the depth measuring device on the slit-lamp microscope. Eyes with (i) a fluorescein retention score of <0.5, (ii) corneal opacity >0.5, or, (iii) any additional signs of damage were replaced. For eyes that are not rejected based on any of these criteria, individual eyes with a corneal thickness deviating more the 10% from the mean value for all eyes were also rejected.
EQUILIBRATION AND BASELINE RECORDINGS
All examined and approved eyes were incubated between 45 and 64 minutes to equilibrate them to the test system prior to dosing. Following the equilibration period, a zero reference measurement was recorded for corneal thickness and opacity to serve as baseline. The fluorescein score determined at dissection was used as the baseline measurement for that endpoint.
NUMBER OF REPLICATES
3 replicates for the test item, 3 replicates for the posisitve control, 1 replicate for the negative control
NEGATIVE CONTROL USED
yes, physiological saline
POSITIVE CONTROL USED
yes, Benzalkonium chloride, 5% in physiological saline
APPLICATION DOSE AND EXPOSURE TIME
Immediately following the zero reference measurements, the eye (in its holder) was removed from the superfusion apparatus, placed in a horizontal position, and 30 µL of the test item was applied, as supplied, to the cornea such that the entire surface of the cornea was evenly covered with the test item. The test item was applied for 10 seconds and then rinsed from the eye with 20 mL of physiological saline at ambient temperature. The eye (in its holder) was subsequently returned to the superfusion apparatus in the original upright position.
OBSERVATION PERIOD
Treated corneas were evaluated pretreatment and starting at 30, 75, 120, 180, and 240 minutes (± 5 minutes) after the post-treament rinse.
REMOVAL OF TEST SUBSTANCE
- Volume and washing procedure after exposure period: rinsed from the eye with 20 mL of physiological saline at ambient temperature
- Indicate any deviation from test procedure in the Guideline : The eyes were incubated between 45 and 64 minutes instead of between 45 and 60 minutes, as initially scheduled. As the results obtained with the eyes treated with the negative control which has the longest duration of acclimation were conformed to what expected, this deviation is considered as without impact on the results of the study.
METHODS FOR MEASURED ENDPOINTS:
All observations of the cornea and measurement of corneal thickness were performed using a Haag-Streit BP900 slit-lamp microscope with depth-measuring device no. I. For the measurement of corneal thickness the slit-width was set at 9 1/2, equally 0.095 mm. Corneal opacity was calculated by using the area of the cornea that was most densely opacified for scoring. The mean corneal opacity value for all test eyes was calculated for all observation time points. Based on the highest mean score for corneal opacity as observed at any time point, an overall category score was then given for each test or control item. The endpoints evaluated were corneal opacity, swelling, fluorescein retention, and morphological effects (e.g. pitting or loosening of the epithelium). All of the endpoints, with the exception of fluorescein retention were determined at each of the above time points. Corneal swelling was determined from corneal thickness measurements made with an optical pachymeter on a slit-lamp microscope and was expressed as a percentage. The mean percentage of corneal swelling for all test eyes was calculated for all observation time points. Based on the highest mean score for corneal swelling, as observed at any time point, an overall category score was then given for each test item. The mean fluorescein retention value for all test eyes was calculated for the 30-minute observation time point only, which was used for the overall category score given for each test or control item. Morphological effects include "pitting" of corneal epithelial cells, "loosening" of epithelium, "roughening" of the corneal surface and "sticking" of the test item to the cornea. The classification of these findings is subjective to the interpretation of the investigator.
SCORING SYSTEM:
- Mean corneal swelling (%) : according to guideline
- Mean maximum opacity score : according to guideline
- Mean fluorescein retention score at 30 minutes post-treatment ; according to guideline
DECISION CRITERIA: decision criteria as indicated in the TG was used.
Results and discussion
In vitro
Resultsopen allclose all
- Irritation parameter:
- cornea opacity score
- Remarks:
- maximal mean score
- Value:
- 1
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: corresponding to ICE class II
- Irritation parameter:
- fluorescein retention score
- Remarks:
- mean score
- Value:
- 3
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: corresponding to ICE class IV
- Irritation parameter:
- percent corneal swelling
- Remarks:
- maximal mean swelling
- Value:
- 2
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: corresponding to ICE class I
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: At all examination time points no morphological effects were noted in the negative control and the test item treated eyes. The eyes treated with the positive control showed blisters on the cornea from 30 minutes post-dose in all 3 tested eyes.
DEMONSTRATION OF TECHNICAL PROFICIENCY:
The combination of the three endpoint for the negative control (physiological saline) was 3 x I, therefore the negative control is classified as "No category", as expected.
The combination of the three endpoints for the positive control (5% Benzalkonium chloride) was 2 x IV, 1 x III, therefore the positive control is classified as "Corrosive/Severe Irritant", as expected.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes
- Acceptance criteria met for positive control: yes
- Range of historical values if different from the ones specified in the test guideline: not different
The ocular reactions observed in eyes treated with the test item were: - maximal mean score of corneal opacity: 1.0, corresponding to ICE class II; - mean score of fluorescein retention: 3.0, corresponding to ICE class IV; - maximal mean corneal swelling: 2%, corresponding to ICE class I.
The combination of the three endpoints for the test ISOFOL ESTER 4693 (Reaction product of guerbet alcohols, C24-26,branched and cyclic with 1,2,4-benzenetricarboxylic acid) was 1 x IV, 1 x II, 1 x I.
A test item that is not predicted as causing serious eye damage with the ICE test method would require additional testing (in vitro and/or in vivo) to establish a definitive classification.
Any other information on results incl. tables
Table #1: Values for Evaluation of Corneal Lesions after Treatment with Test Item
Endpoint measured | Eye No. | Time (min) | |||||
|
|
0 |
30 |
75 |
120 |
180 |
240 |
Corneal opacity |
4 |
0 |
1 |
1 |
1 |
1 |
1 |
|
5 |
0 |
1 |
1 |
1 |
1 |
1 |
|
6 |
0 |
1 |
1 |
1 |
1 |
1 |
Mean |
|
0.0 |
1.0 |
1.0 |
1.0 |
1.0 |
1.0 |
ICE class |
|
II |
|||||
Fluorescein retention |
4 |
0.5 |
3 |
- |
- |
- |
- |
|
5 |
0.5 |
3 |
- |
- |
- |
- |
|
6 |
0.5 |
3 |
- |
- |
- |
- |
Mean |
|
0.5 |
3.0 |
- |
- |
- |
- |
ICE class |
|
IV |
- |
- |
- |
- |
|
Corneal thickness |
4 |
0.60 |
0.60 |
0.62 |
0.62 |
0.62 |
0.62 |
|
5 |
0.58 |
0.58 |
0.58 |
0.58 |
0.58 |
0.58 |
|
6 |
0.58 |
0.58 |
0.58 |
0.58 |
0.58 |
0.58 |
Corneal swelling (%) |
4 |
- |
0 |
3 |
3 |
3 |
3 |
|
5 |
- |
2 |
2 |
2 |
2 |
2 |
|
6 |
- |
2 |
2 |
2 |
2 |
2 |
Mean |
|
- |
1 |
2 |
2 |
2 |
2 |
ICE class |
|
I | |||||
Combination of 3 endpoints |
|
1 x IV, 1 x II, 1 x I |
|||||
Classification |
|
no prediction can be made |
Table #2: Values for Evaluation of Corneal Lesions after Treatment with Positive Control (5% (w/v) Benzalkonium chloride
Endpoint measured | Eye No. | Time (min) | |||||
|
|
0 |
30 |
75 |
120 |
180 |
240 |
Corneal opacity |
1 |
0 |
3 |
3 |
3 |
3 |
3 |
|
2 |
0 |
3 |
3 |
3 |
3 |
3 |
|
3 |
0 |
3 |
3 |
3 |
3 |
3 |
Mean |
|
0.0 |
3.0 |
3.0 |
3.0 |
3.0 |
3.0 |
ICE class |
|
IV |
|||||
Fluorescein retention |
1 |
0.5 |
3 |
- |
- |
- |
- |
|
2 |
0.5 |
3 |
- |
- |
- |
- |
|
3 |
0.5 |
3 |
- |
- |
- |
- |
Mean |
|
0.5 |
3.0 |
- |
- |
- |
- |
ICE class |
|
IV |
- |
- |
- |
- |
|
Corneal thickness |
1 |
0.58 |
0.65 |
0.68 |
0.72 |
0.75 |
0.78 |
|
2 |
0.60 |
0.68 |
0.74 |
0.76 |
0.79 |
0.79 |
|
3 |
0.61 |
0.63 |
0.69 |
0.70 |
0.78 |
0.78 |
Corneal swelling (%) |
1 |
- |
12 |
17 |
24 |
29 |
34 |
|
2 |
- |
13 |
23 |
27 |
32 |
32 |
|
3 |
- |
3 |
13 |
15 |
28 |
28 |
Mean |
|
- |
10 |
18 |
22 |
30 |
31 |
ICE class |
|
III | |||||
Combination of 3 endpoints |
|
2 x IV, 1 x III |
|||||
Classification |
|
Category 1: Corrosive / Severe irritant |
Table #3: Values for Evaluation of Corneal Lesions after Treatment with Negative Control (Physiological Saline)
Endpoint measured | Eye No. | Time (min) | |||||
|
|
0 |
30 |
75 |
120 |
180 |
240 |
Corneal opacity |
16 |
0 |
0 |
0 |
0 |
0 |
0 |
ICE class |
|
I |
|||||
Fluorescein retention |
16 |
0 |
0 |
- |
- |
- |
- |
ICE class |
|
I |
- |
- |
- |
- |
|
Corneal thickness |
16 |
0.58 |
0.58 |
0.58 |
0.58 |
0.58 |
0.58 |
Corneal swelling (%) |
16 |
- |
0 |
0 |
0 |
0 |
0 |
ICE class |
|
I | |||||
Combination of 3 endpoints |
|
3 x I |
|||||
Classification |
|
No category |
Applicant's summary and conclusion
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- The results obtained under these experimental conditions lead to the category "no prediction can be made", as defined in the guideline OECD No. 438, therefore the test item is not predicted as causing serious eye damage (Category I) or as not classified for eye irritation/serious eye damage (No Category) with the Isolated Chicken Eye test method.
- Executive summary:
The aim of the study was to evaluate the possible ocular corrosive or severe irritating effects of the test item after administration on enucleated chicken eyes.
The test item Reaction product of guerbet alcohols, C24-26,branched and cyclic with 1,2,4-benzenetricarboxylic acid was applied, as supplied, at the dose of 30 µL, to 3 enucleated chicken eyes, during 10 seconds. Then the eyes were rinsed twice with 10 mL of physiological saline. Three eyes were treated in the same manner with a positive control and one eye with a negative control. Damages by the test item were assessed by determination of corneal swelling, opacity, and fluorescein retention at 30, 75, 120, 180 and 240 minutes post-dose. The experimental protocol was established in accordance with the O.E.C.D. Test Guideline No. 438 adopted 25 June 2018 and the test method B.48 – Commission Regulation (EU) No. 1152/2010 dated 08 December 2010 (EU Journal L324) - ATP Council regulation No. 440/2008 of 30 May 2008 (E.U. Journal L142).
The ocular reactions observed in eyes treated with the test item were: - maximal mean score of corneal opacity: 1.0, corresponding to ICE class II; - mean score of fluorescein retention: 3.0, corresponding to ICE class IV; - maximal mean corneal swelling: 2%, corresponding to ICE class I.
The combination of the three endpoints for the test ISOFOL ESTER 4693 (Reaction product of guerbet alcohols, C24-26,branched and cyclic with 1,2,4-benzenetricarboxylic acid) was 1 x IV, 1 x II, 1 x I.
The combination of the three endpoints for the positive control, 5% Benzalkonium chloride, was 2 x IV, 1 x III. Therefore, the positive control is classified as “Corrosive/Severe Irritant”, as expected.
The combination of the three endpoints for the negative control, physiological saline, was 3 x I. Therefore, the negative control is classified as “No Category”, as expected.
In accordance with the Regulation (EC) No. 1272/2008, the results obtained under these experimental conditions lead to the category “no prediction can be made”, as defined by the OECD guideline No.438. Therefore, the test item Reaction product of guerbet alcohols, C24-26,branched and cyclic with 1,2,4-benzenetricarboxylic acid is not predicted as causing serious eye damage (Category 1) or as not classified for eye irritation/serious eye damage (No category) with the Isolated Chicken Eye test method. Additional testing (in vitro and/or in vivo) is required to establish a definitive classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.